ALPELISIB, ALPELISIB, ALPELISIB
Phase 3 small_molecule active
Quick answer
ALPELISIB, ALPELISIB, ALPELISIB for PIK3CA mutated HER2+ advanced or relapsed breast cancer (BC) previously treated with trastuzumab is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- PIK3CA mutated HER2+ advanced or relapsed breast cancer (BC) previously treated with trastuzumab
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active